Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) ELISA Kits

The protein encoded by TNFRSF8 is a member of the TNF-receptor superfamily. Zusätzlich bieten wir Ihnen TNFRSF8 Antikörper (696) und TNFRSF8 Proteine (21) und viele weitere Produktgruppen zu diesem Protein an.

list all ELISA KIts Gen GeneID UniProt
TNFRSF8 943 P28908
TNFRSF8 21941 Q60846
TNFRSF8 25069 P97525
Direkt bei antikoerper-online bestellen
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Online bestellen
  • orders@antikoerper-online.de

Top TNFRSF8 ELISA Kits auf antikoerper-online.de

Showing 6 out of 34 products:

Katalog Nr. Reaktivität Sensitivität Bereich Bilder Menge Anbieter Lieferzeit Preis Details
Human 3.9 pg/mL 15.6-1000 pg/mL Typical standard curve 96 Tests Anmelden zum Anzeigen 13 bis 16 Tage
$910.56
Details
Maus 10pg/mL 15.6-1000 pg/mL Mouse CD30 PicoKine ELISA Kit standard curve 96 Tests Anmelden zum Anzeigen 4 bis 6 Tage
$369.00
Details
Ratte 0.135 ng/mL 0.31-20 ng/mL 96 Tests Anmelden zum Anzeigen 13 bis 16 Tage
$640.00
Details
Human 21 pg/mL 78-5000 pg/mL   96 Tests Anmelden zum Anzeigen 2 bis 3 Tage
$691.90
Details
Ratte 0.135 ng/mL 0.312-20 ng/mL Typical Standard Curve 96 Tests Anmelden zum Anzeigen 15 bis 17 Tage
$973.11
Details
Maus 15.6-1000 pg/mL   96 Tests Anmelden zum Anzeigen 2 bis 3 Tage
$713.90
Details

Weitere ELISA Kits für TNFRSF8 Interaktionspartner

Human Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) Interaktionspartner

  1. Variant histology is common in pediatric NLPHL, especially types C and E, which are associated with IgD expression. Type C variant histology and possibly type D are associated with decreased EFS (zeige EFS ELISA Kits), but neither IgD nor CD30 are adverse features. Variant histology may warrant increased surveillance, but did not affect overall survival.

  2. Expression of CD30 in patients with both DLBCL and other aggressive B-cell lymphomas and the absence of MYC (zeige MYC ELISA Kits) oncogene (zeige RAB1A ELISA Kits)-driven proliferation in the majority of these tumors suggests that brentuximab may be a particularly effective form of targeted therapy in the subset of patients with high CD30 expression.

  3. Prevalence of the CD30 (Ki-1) antigen in human solid tumors was summarized.

  4. CD30 expression was detected in up to 25% of cases of diffuse large B-cell lymphoma and was more frequent in tumors without MYC (zeige MYC ELISA Kits) rearrangement. CD30 expression was not associated with overall survival in R-EPOCH-treated de novo DLBCL patients.

  5. CD30 facilitates phosphorylation of heat shock factor 1, activates heat shock promoter element, and induces heat shock protein (HSP) 90 (zeige HSP90AA1 ELISA Kits).

  6. this study shows that polyclonal and allogeneic stimulation induced higher levels of CD30 transcripts in end-stage renal disease patients compared to control patients

  7. CD30 expression was not associated with prognosis in our cohort of de novoDLBCL, including in patients who received aggressive chemotherapy. CD30 expression and MYC (zeige MYC ELISA Kits) rearrangement were mutually exclusive in de novoDLBCL.

  8. Case Report: CD30 positive lymphomatoid papulosis arising in association with cutaneous amyloidosis in a patient with multiple myeloma.

  9. The heterogeneity of CD30 expression in refractory or relapsed peripheral T-cell lymphoma patients indicates the likelihood for better response for patients with strong CD30 expression by tumor cells.

  10. CD30 may be useful as a prognostic marker in rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP (zeige DDIT3 ELISA Kits)) treated DLBCLs, indicating favorable outcomes in a Chinese population.

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8) Interaktionspartner

  1. This study demonstrated the amelioration of MOG35-55 peptide-induced active EAE in CD30 KO mice. CD30 was expressed limitedly on CD4 (zeige CD4 ELISA Kits) T cells at the induction phase of experimental autoimmune encephalomyelitis.

  2. Data indicate that CD30L (zeige TNFSF8 ELISA Kits)/CD30 axis plays a modulatory role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE).

  3. role in the maintenance and activation of IL-17A (zeige IL17A ELISA Kits)-producing gammadelta T cells

  4. These results suggest that CD30 signaling plays an important role in the activation of IL-17A (zeige IL17A ELISA Kits)-producing Vgamma1(-) Vgamma4(-) gammadelta T cells bearing Vgamma6 at an early stage of BCG (zeige SLC11A1 ELISA Kits) infection.

  5. Interference of the CD30-CD30L (zeige TNFSF8 ELISA Kits) pathway reduces atherosclerosis development.

  6. CD30L (zeige TNFSF8 ELISA Kits)/CD30 pathway acts as an accelerator of enteritis in a murine disease model

  7. role of CD30L (zeige TNFSF8 ELISA Kits)/CD30 interactions in allergic rhinitis; results suggest that CD30L (zeige TNFSF8 ELISA Kits) plays an important role in allergic rhinitis

  8. Abrogation of CD30 and OX40 (zeige TNFRSF4 ELISA Kits) signals prevents autoimmune disease in FoxP3 (zeige FOXP3 ELISA Kits)-deficient mice.

  9. Studies demonstrate that CD30L (zeige TNFSF8 ELISA Kits)/CD30 signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation.

  10. CD30 can signal in a completely TCR-independent fashion to induce IL-13 (zeige IL13 ELISA Kits) production by effector T cells.

TNFRSF8 Antigen-Profil

Beschreibung des Gens

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the activation of NF-kappaB. This receptor is a positive regulator of apoptosis, and also has been shown to limit the proliferative potential of autoreactive CD8 effector T cells and protect the body against autoimmunity. Two alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported.

Genbezeichner und Symbole assoziert mit TNFRSF8

  • TNF receptor superfamily member 8 (TNFRSF8) Antikörper
  • tumor necrosis factor receptor superfamily, member 8 (Tnfrsf8) Antikörper
  • TNF receptor superfamily member 8 (Tnfrsf8) Antikörper
  • TNF superfamily member 8 (TNFSF8) Antikörper
  • Cd30 Antikörper
  • D1S166E Antikörper
  • Ki Antikörper
  • Ki-1 Antikörper
  • TNFRSF8 Antikörper

Bezeichner auf Proteinebene für TNFRSF8

CD30L receptor , Ki-1 antigen , cytokine receptor CD30 , lymphocyte activation antigen CD30 , tumor necrosis factor receptor superfamily member 8 , Tumor necrosis factor superfamily member 8 , tumor necrosis factor superfamily, member CD30 , tumor necrosis factor receptor superfamily, member 8 , tumor necrosis factor ligand superfamily member 8 , tumor necrosis factor receptor superfamily member 8-like

GENE ID SPEZIES
943 Homo sapiens
21941 Mus musculus
25069 Rattus norvegicus
395090 Gallus gallus
457960 Pan troglodytes
487438 Canis lupus familiaris
574055 Sus scrofa
574056 Bos taurus
614780 Bos taurus
722773 Macaca mulatta
100385465 Callithrix jacchus
100579424 Nomascus leucogenys
Ausgewählte Anbieter für TNFRSF8 (TNFRSF8) ELISA Kits
Haben Sie etwas anderes gesucht?